Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Malar J ; 11: 252, 2012 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-22853699

RESUMEN

BACKGROUND: Plasmodium falciparum and HIV-1 infection cause substantial morbidity and mortality in sub-Saharan Africa. Increasing evidence suggests these two pathogens interact negatively when infecting the same individual. METHODS: A cross-sectional study among HIV-1 infected and uninfected populations was recruited in Mocuba and Maputo, Mozambique to determine the prevalence of sub-clinical malarial parasitaemia using light microscopy and a nested PCR assay. RESULTS: The prevalence of sub-clinical P. falciparum parasitaemia was low in Maputo, whether determined by microscopy (0.4%) or PCR (1.9%), but substantially higher in Mocuba (7.6 and 14.7%, respectively). Nested PCR detected nearly 70% more cases of sub-clinical parasitaemia than microscopy, but differences occur by locality. HIV-1 infected persons were more likely to be sub-clinically parasitaemic than HIV-1 uninfected individuals recruited from the same geographic areas. Trimethoprim-sulphamethoxazole use did not substantially reduce sub-clinical parasitaemia. CONCLUSIONS: Dried blood spots are a convenient and sensitive technique for detecting sub-clinical infection with P. falciparum by nested PCR. Prevalence of P. falciparum is substantially lower in Maputo where malaria control programmes have been more active than in the rural town of Mocuba. In Mocuba, among those presenting for HIV-1 counseling and testing, the prevalence of P. falciparum is substantially higher in those who test positive for HIV-1 than those without HIV-1 infection. The clinical implications of sub-clinical P. falciparum infection among HIV-1 infected persons warrant additional study.


Asunto(s)
Infecciones por VIH/complicaciones , Malaria Falciparum/epidemiología , Adolescente , Adulto , Anciano , Infecciones Asintomáticas/epidemiología , Sangre/parasitología , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mozambique/epidemiología , Parasitemia/epidemiología , Reacción en Cadena de la Polimerasa/métodos , Prevalencia , Estudios Prospectivos , Adulto Joven
2.
Laryngoscope ; 123(11): 2598-600, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23670536

RESUMEN

OBJECTIVES/HYPOTHESIS: When combined with local sphenopalatine (SP) injection and moderate hypotension, transoral or transcutaneous local injection of the anterior palatine (AP) vessels reduces intraoperative bleeding in hereditary hemorrhagic telangiectasia (HHT) patients undergoing nasal surgery. STUDY DESIGN: Retrospective chart review of 55 consecutive HHT patients undergoing a bevacizumab injection for recalcitrant epistaxis. Nineteen patients received local injections to only the SP vasculature, and 36 patients received AP and SP injections. METHODS: Main outcome variable was estimated blood loss during nasal surgery. Independent variables included sex, age, epistaxis severity score, surgical techniques (including laser), and blood pressure parameters (baseline, preinduction, and postintubation). RESULTS: The mean blood loss in HHT patients receiving SP injections alone was 111 mL, whereas it was 22 mL for those receiving both AP + SP injections. This difference between groups approached statistical significance (P = .075). Blood pressure parameters were similar in both groups with no appreciable difference between intraoperative systolic and mean arterial blood pressure. CONCLUSIONS: The addition of either sublabial or transcutaneous AP injection to the standard SP block markedly reduces blood loss in HHT epistaxis nasal surgery.


Asunto(s)
Anticuerpos Monoclonales Humanizados/administración & dosificación , Pérdida de Sangre Quirúrgica/prevención & control , Epistaxis/etiología , Epistaxis/prevención & control , Procedimientos Quírurgicos Nasales , Telangiectasia Hemorrágica Hereditaria/complicaciones , Bevacizumab , Femenino , Humanos , Inyecciones , Masculino , Persona de Mediana Edad , Hueso Paladar , Estudios Retrospectivos
3.
Virology ; 369(2): 234-44, 2007 Dec 20.
Artículo en Inglés | MEDLINE | ID: mdl-17825342

RESUMEN

The genome sequence of the Salmonella enterica serovar Anatum-specific, serotype-converting bacteriophage epsilon15 has been completed. The nonredundant genome contains 39,671 bp and 51 putative genes. It most closely resembles the genome of phiV10, an Escherichia coli O157:H7-specific temperate phage, with which it shares 36 related genes. More distant relatives include the Burkholderia cepacia-specific phage, BcepC6B (8 similar genes), the Bordetella bronchiseptica-specific phage, BPP-1 (8 similar genes) and the Photobacterium profundum prophage, P Pphipr1 (6 similar genes). epsilon15 gene identifications based on homologies with known gene families include the terminase small and large subunits, integrase, endolysin, two holins, two DNA methylase enzymes (one adenine-specific and one cytosine-specific) and a RecT-like enzyme. Genes identified experimentally include those coding for the serotype conversion proteins, the tail fiber, the major capsid protein and the major repressor. epsilon15's attP site and the Salmonella attB site with which it interacts during lysogenization have also been determined.


Asunto(s)
Genoma Viral , Fagos de Salmonella/genética , Salmonella enterica/virología , Secuencia de Aminoácidos , Tipificación de Bacteriófagos , Secuencia de Bases , ADN Bacteriano/genética , ADN Viral/genética , Datos de Secuencia Molecular , Fagos de Salmonella/clasificación , Fagos de Salmonella/fisiología , Salmonella enterica/clasificación , Salmonella enterica/genética , Homología de Secuencia de Ácido Nucleico , Serotipificación , Especificidad de la Especie , Proteínas Virales/genética , Ensamble de Virus , Integración Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA